Exchange: OTC·Updated 04:02 PM EDT

ALPMY ASTELLAS PHARMA/ADR

$15.95
$0.18
(1.14%)
Today
Closed $15.95
$0.00
(0.00%)
After Hours
EarningsNov 4
Mkt Cap$28.6B
Vol95,873.00

About ALPMY

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
50

Neutral Sentiment

How do you feel about ALPMY?

Advertisement|Remove ads.